SHILPA MEDICARE LTD.

Company Profile

SHILPA MEDICARE LTD. had its IPO on under the ticker symbol SHILPAMED.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. SHILPA MEDICARE LTD. has a staff strength of 0 employees.

Stock update

Shares of SHILPA MEDICARE LTD. opened at ₹366 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹349.35 - ₹368.2, and closed at ₹352.55.

This is a -3.56% slip from the previous day's closing price.

A total volume of 35,078 shares were traded at the close of the day’s session.

In the last one week, shares of SHILPA MEDICARE LTD. have slipped by -5.47%.

SHILPA MEDICARE LTD.'s Key Ratios

SHILPA MEDICARE LTD. has a market cap of ₹21.08 billion, indicating a price to book ratio of 1.4166 and a price to sales ratio of 2.2334.

In the last 12-months SHILPA MEDICARE LTD.’s revenue was ₹9.70 billion with a gross profit of ₹6.00 billion and an EBITDA of ₹2.56 billion. The EBITDA ratio measures SHILPA MEDICARE LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SHILPA MEDICARE LTD.’s operating margin was 21.79% while its return on assets stood at 6.12% with a return of equity of 0%.

In Q4, SHILPA MEDICARE LTD.’s quarterly earnings growth was a positive 448.7% while revenue growth was a positive 38.4%.

SHILPA MEDICARE LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

9.3635

PEG

Its diluted EPS in the last 12-months stands at ₹27.81 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SHILPA MEDICARE LTD.’s profitability.

SHILPA MEDICARE LTD. stock is trading at a EV to sales ratio of 2.9041 and a EV to EBITDA ratio of 19.3231. Its price to sales ratio in the trailing 12-months stood at 2.2334.

SHILPA MEDICARE LTD. stock pays annual dividends of ₹1.1 per share, indicating a yield of 0.42% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹29.83 billion

Total Liabilities

₹8.56 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

SHILPA MEDICARE LTD. ended 2024 with ₹29.83 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹29.83 billion while shareholder equity stood at ₹17.97 billion.

SHILPA MEDICARE LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹8.56 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹456.23 million in goodwill. Its cash balance stood at ₹473.37 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹2.66 billion.

SHILPA MEDICARE LTD.’s total current assets stands at ₹9.09 billion while long-term investments were ₹0 and short-term investments were ₹155.05 million. Its net receivables were ₹3.75 billion compared to accounts payable of ₹1.78 billion and inventory worth ₹3.64 billion.

In 2024, SHILPA MEDICARE LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, SHILPA MEDICARE LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹352.55

52-Week High

₹468.6568

52-Week Low

₹222.4

Analyst Target Price

₹

SHILPA MEDICARE LTD. stock is currently trading at ₹352.55 per share. It touched a 52-week high of ₹468.6568 and a 52-week low of ₹468.6568. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹343.05 and 200-day moving average was ₹280.56 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7500.4% of the company’s stock are held by insiders while 940.9% are held by institutions.